Does Wrapping With Bone Marrow Injection Enhance Healing of Meniscal Sutures Into the Avascular Area
NCT ID: NCT03968029
Last Updated: 2023-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
128 participants
INTERVENTIONAL
2017-07-28
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
This is a Study to Verify if Marrow Venting Procedure Can Improve Meniscal Suture Healing
NCT05053646
Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression
NCT02289976
Study of the Concordance of the Measurements Between the Evaluation of the Area of a Wound by the Technique of Transparent (Gold Standard) Compared to the Evaluation of the Area by the Algorithm of a Decision Support System (Wound-size)
NCT05846152
Pain, Function and Quality of Life Before and After Treatment of Hamstring Avulsion
NCT03868826
Registry of Amniotic Membrane: Evaluating Utilization and Outcomes in Various Applications
NCT04222166
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Suturing meniscal augmented
Non-vascularised area meniscus tear was sutured and bone marrow was injected under a protective collagen membrane (ChondroGide)
suturing meniscal augmented
meniscal tear sutured + bone marrow injection/collagen membrane
Suturing meniscal
Non-vascularised area meniscus tear was only sutured
suturing meniscal
meniscal tear sutured
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
suturing meniscal augmented
meniscal tear sutured + bone marrow injection/collagen membrane
suturing meniscal
meniscal tear sutured
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tearing affecting: only 2/3 central (= avascular zone) over more than 1 cm OR extending from the peripheral third (= vascularized area) within the avascular zone over more than 1 cm. In this case, preservation of the peripheral third over a width of at least 4 mm from the capsule;
* Single or multiple tears.
Exclusion Criteria
* Tear creating a meniscal root avulsion
* Partial meniscal tears
* Meniscal tears already sutured
* Cartilage damage in the compartment\> grade 2 (ICRS classification)
* Mechanical axis (varus / valgus) ≥ 2 °
* Untreated ligament deficiency
* Osteotomy and / or concomitant ligament reconstruction, with the exception of ACL reconstruction.
* Compromised general health condition (score ASA score\> 2)
* BMI ≥30
* Active smoking, drug use
* Allergy to porcine collagen
* Poor compliance
15 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Vaudois
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Robin Martin
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robin MARTIN, MD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire Vaudois
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier Universitaire Vaudois - CHUV
Lausanne, Canton of Vaud, Switzerland
Dr Robin MARTIN
Lausanne, Canton of Vaud, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MW_OTR
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.